Pre-salvage ISS and Other Important Outcome Associations in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma

INTRODUCTION: Despite ongoing therapeutic advances multiple myeloma (MM) remains largely incurable, and outcomes in patients who develop resistance to IMiD or proteasome inhibitor therapies remain grim. Allogeneic hematopoietic cell transplant (alloHCT) is an alternate option that may offer potentia...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	Biol Blood Marrow Transplant
Main Authors:	Bryant, AR, Hilden, P, Giralt, S, Chung, DJ, Maloy, M, Landau, H, Landgren, O, Scordo, M, Shah, G, Smith, EL, O’Reilly, RJ, Perales, M-A, Koehne, G
Format:	Artigo
Sprog:	Inglês
Udgivet:	2019
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7470026/ https://ncbi.nlm.nih.gov/pubmed/31493537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2019.08.023
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Pre-salvage ISS and Other Important Outcome Associations in CD34 Selected Allogeneic Hematopoietic Stem Cell Transplant for Multiple Myeloma

Lignende værker